share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOSHOFF CHRISTOFFEL

SEC announcement ·  Mar 2 02:30
Summary by Futu AI
On February 28, 2024, Pfizer Inc's Executive Vice President, Christoffel Boshoff, completed a transaction involving the company's common stock. Boshoff sold 4,150 shares at a price of $27.04 per share, resulting in a total market value of $112,216. The transaction was part of a payment for exercise price or tax liability by delivering or withholding securities. Additionally, Boshoff acquired 11,510 shares on the same date at no cost, which was reported as a grant, award, or other acquisition. Following these transactions, Boshoff directly holds 156,007 shares of Pfizer common stock. Separately, Boshoff also has an indirect beneficial ownership of 624 shares through a Rule 16b-3 Plan.
On February 28, 2024, Pfizer Inc's Executive Vice President, Christoffel Boshoff, completed a transaction involving the company's common stock. Boshoff sold 4,150 shares at a price of $27.04 per share, resulting in a total market value of $112,216. The transaction was part of a payment for exercise price or tax liability by delivering or withholding securities. Additionally, Boshoff acquired 11,510 shares on the same date at no cost, which was reported as a grant, award, or other acquisition. Following these transactions, Boshoff directly holds 156,007 shares of Pfizer common stock. Separately, Boshoff also has an indirect beneficial ownership of 624 shares through a Rule 16b-3 Plan.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.